Monday, February 25th, 2008
CRME +30% as FDA is about to make decision
CRME - Cardiome Pharma (CRME message board) is up 30% as investors await the FDA decision on their Kynapid drug which restores normal heart rhythem in patients with arterial fibrillation.
